Genetic investigations pathway for people with intellectual disability, autism and/or epilepsy

被引:1
|
作者
Clark, Elaine [1 ]
Koutsogianni, Maria [2 ]
机构
[1] Great Ormond St Hosp Children NHS Fdn Trust, Neurodisabil Team, London, England
[2] Great Ormond St Hosp Children NHS Fdn Trust, Canc Genet Clin Genet Team, London, England
关键词
Autism spectrum disorders; intellectual disability; developmental disorders; genetics; epilepsy; LARGE-SCALE; RISK; MUTATION; ADULTS;
D O I
10.1192/bja.2022.44
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Genomic medicine is an evolving medical specialty that uses genomic information about an individual as part of their clinical care (e.g. for diagnostic or therapeutic decision-making). It has rapidly grown since the completion of the Human Genome Project in 2003. In England, the National Health Service's Genomic Medicine Service is considered to be the first national healthcare system to offer whole-genome sequencing as part of routine clinical care. Already, genomic medicine is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, infectious disease and neurology. In this article, we present a useful tool kit for clinicians working with individuals with intellectual disability, autism spectrum disorder and epilepsy. This article provides evidence for the importance of genetic testing, conveys an understanding of the range of genetic tests available and their diagnostic yields and how these apply to intellectual disability, autism spectrum disorder and epilepsy. Our simple tool kit gives information on when to refer to a clinical geneticist and where to find resources for clinicians and parents on genetic testing.
引用
收藏
页码:353 / 362
页数:10
相关论文
共 50 条
  • [31] Autism and intellectual disability
    E Tallantyre
    Neil P. Robertson
    [J]. Journal of Neurology, 2013, 260 (3) : 936 - 939
  • [32] The synapsins: from organization of synaptic terminals to epilepsy, autism and intellectual disability
    Valtorta, F.
    Benfenati, F.
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 53 : S127 - S127
  • [33] Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability
    Ylinen, A
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1998, 42 : 46 - 49
  • [34] KNOWLEDGE OF EPILEPSY BY CAREGIVERS WORKING IN AN INSTITUTION FOR PEOPLE WITH AN INTELLECTUAL DISABILITY
    Peeters, H. P. J. A.
    Graveland, G. A.
    Soekhoe, R.
    Meijs, T. H. J.
    Schelhaas, J. H. J.
    [J]. EPILEPSIA, 2015, 56 : 129 - 129
  • [35] Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability
    Iivanainen, M
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1998, 42 : 24 - 31
  • [36] Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability
    Alvarez, N
    Besag, F
    Iivanainen, M
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1998, 42 : 1 - 15
  • [37] Awareness of bone health risks in people with epilepsy and intellectual disability
    Sawhney, Indermeet
    Zia, Asif
    Yazdi, Bahar
    Shankar, Rohit
    [J]. BRITISH JOURNAL OF LEARNING DISABILITIES, 2020, 48 (03) : 224 - 231
  • [38] Age-related fractures in people with intellectual disability and epilepsy
    Jancar, J
    Jancar, MP
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1998, 42 : 429 - 433
  • [39] Topiramate: uses in people with an intellectual disability who have epilepsy
    Kerr, MP
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1998, 42 : 74 - 79
  • [40] Awareness of social care needs in people with epilepsy and intellectual disability
    Triantafyllopoulou, P.
    Tromans, S.
    Newman, H.
    Triantafyllaopoulou, P.
    Hassiotis, A.
    Bassett, P.
    Sawhney, I.
    Watkins, L.
    Griffiths, L.
    Pullen, A.
    Roy, A.
    Angus-Leppan, H.
    Cooper, M.
    Thomas, R. H.
    Kinney, M.
    Tittensor, P.
    Shankar, R.
    [J]. EPILEPSY & BEHAVIOR, 2023, 145